EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Open Access · CC BY 4.0

Ferric derisomaltose for the treatment of iron deficiency anemia with postpartum hemorrhage: Results of a single‐arm, open‐label, phase 3 study in Japan

Motoi Sugimura iD, Yasuyoshi Ohtani, Soichiro Tamai, Umi Kishimoto, Naoki Ito

Journal of Obstetrics and Gynaecology Research · 2023

DOI: 10.1111/jog.15546 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2023. Verfasst von Motoi Sugimura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology and Family Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency, Postpartum Hemorrhage, Depression, Postpartum. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nippon Shinyaku Co., Ltd., Nippon Shinyaku.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Single‐arm, open‐label, phase 3 study to evaluate the efficacy and safety of ferric derisomaltose (FDI) for iron deficiency anemia (IDA) in Japanese women with postpartum hemorrhage (PPH).

Methods

Postpartum women aged 20–39 years with serum ferritin

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Iron-DeficiencyPostpartum HemorrhageDepression, PostpartumAdultPregnancyInfant, NewbornHumansFemaleMaltoseJapanFerric CompoundsIronHemoglobinsFerritinsDisaccharides

Stichwörter der Autor:innen

ferric derisomaltoseintravenous iron preparationiron deficiency anemiamaternal milkpostpartum hemorrhage

Substanzen

MaltoseFerric CompoundsIronHemoglobinsFerritinsferric derisomaltoseDisaccharides

Autor:innen und Institutionen

  • Department of Obstetrics, Gynecology and Family Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
  • Research and Development Administration Department, Nippon Shinyaku Co. Ltd., Kyoto, Japan.
  • Clinical Development Division, Data Science Department, Nippon Shinyaku Co. Ltd., Kyoto, Japan.
  • Clinical Development Division, Clinical Development Department, Nippon Shinyaku Co. Ltd., Kyoto, Japan.
  • Department of Pediatrics, Teikyo University School of Medicine, Tokyo, Japan.

ORCID-Profile: Motoi Sugimura

Förderung

  • Nippon Shinyaku Co., Ltd.
  • Nippon Shinyaku

Zitieren

APA

Sugimura, M., Ohtani, Y., Tamai, S., Kishimoto, U., & Ito, N. (2023). Ferric derisomaltose for the treatment of iron deficiency anemia with postpartum hemorrhage: Results of a single‐arm, open‐label, phase 3 study in Japan. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.15546

Vancouver

Sugimura M, Ohtani Y, Tamai S, Kishimoto U, Ito N. Ferric derisomaltose for the treatment of iron deficiency anemia with postpartum hemorrhage: Results of a single‐arm, open‐label, phase 3 study in Japan. Journal of Obstetrics and Gynaecology Research. 2023. doi:10.1111/jog.15546

BibTeX
@article{Sugimura2023,
  author = {Sugimura, Motoi and Ohtani, Yasuyoshi and Tamai, Soichiro and Kishimoto, Umi and Ito, Naoki},
  title = {Ferric derisomaltose for the treatment of iron deficiency anemia with postpartum hemorrhage: Results of a single‐arm, open‐label, phase 3 study in Japan},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2023},
  doi = {10.1111/jog.15546}
}
Kostenlos starten →